Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
07/2012
07/19/2012WO2012096411A1 Method for preventing or treating intractable inflammatory bowel disease
07/19/2012WO2012096108A1 Suppressor for increase in blood gip level, suppressor for increase in blood insulin level, postprandial blood triglyceride level reducing agent, and suppressor for increase in blood glucose level
07/19/2012WO2012095849A1 Peptides and compositions for the treatment of neuroectodermal derived tumors and retinoblastoma
07/19/2012WO2012095702A1 A composition for the regeneration of atrophic tissues
07/19/2012WO2012095523A1 Analgesic composition for transbuccal administration
07/19/2012WO2012095508A1 Apol3 for use in the treatment of trypanosoma infectious diseases
07/19/2012WO2012095388A2 Compounds for treatment of feline leukemia in felidae
07/19/2012WO2012095313A1 Treatment and prevention of symptoms of metabolic syndrome
07/19/2012WO2012094755A1 Assessment of igf-1 levels in hiv-infected subjects and uses thereof
07/19/2012WO2012075326A3 Treatment of inflammatory diseases by targeting the adaptor protein ciks
07/19/2012WO2012068553A3 Methods of diagnosing and treating neurodegenerative diseases
07/19/2012WO2012067866A3 Multivalent vaccine for filariasis
07/19/2012WO2012067482A3 ORALLY ADMINISTERED PHARMACEUTICAL COMPOSITION AND PREPARATION METHOD THEREOF, FOR THE PREVENTION AND TREATMENT OF IRRITABLE BOWEL SYNDROME, COMPRISING AN INTESTINAL MOTILITY MODIFIER AND α-D-GALACTOSIDASE
07/19/2012WO2012065106A3 Compounds and related methods for manipulating parp-1-dependent cell death
07/19/2012WO2012064834A3 Methods for organ regeneration
07/19/2012WO2012064792A3 Protein complexes for antigen binding and methods of use
07/19/2012WO2012064627A3 Subcutaneously administered anti-il-6 receptor antibody
07/19/2012WO2012061502A3 Genetic polymorphisms associated with venous thrombosis and statin response, methods of detection and uses thereof
07/19/2012WO2012061466A3 Methods for treating steatotic disease
07/19/2012WO2012051247A3 Egfr-based peptides
07/19/2012WO2012048033A3 Novel compositions for inhibiting virus entry and promoting virolyisis, and methods thereof
07/19/2012WO2012037015A3 Novel lactobacillus salivarius and novel bacteriocin
07/19/2012WO2012036412A3 Peptide having a vascularization-suppressing activity and a use therefor
07/19/2012WO2012027411A3 Compositions and uses of materials with high antimicrobial activity and low toxicity
07/19/2012WO2012021854A3 Treatment of penetrative injury to the brain
07/19/2012WO2012015687A3 Drug-ligand conjugates, synthesis thereof, and intermediates thereto
07/19/2012WO2012014214A3 Peptides derived from plasminogen activator inhibitor-1 (pai-1) for the treatment of hypertension
07/19/2012WO2012009447A3 THE cAMP/PKA/HDAC5 PATHWAY AND USES THEREOF
07/19/2012WO2011159917A3 Growth hormone secretatogue receptor antagonists and uses thereof
07/19/2012WO2011159254A3 The use of des-aspartate-angiotensin i in inflammation-related pathologies and diseases
07/19/2012WO2011133687A3 Methods and compositions for inhibition of beta2-adrenergic receptor degradation
07/19/2012WO2011063989A8 Treatment of nerve injuries
07/19/2012WO2010147484A8 Compositions and methods for treatment of multiple sclerosis
07/19/2012US20120184601 Antiviral oligonucleotides
07/19/2012US20120184498 Dermaseptin b2 used as an inhibitor of the growth of a tumor
07/19/2012US20120184497 Dalbavancin compositions for treatment of bacterial infections
07/19/2012US20120184496 Ophthalmic pharmaceutical compositions of dp2 receptor antagonists
07/19/2012US20120184495 Targeted nano-photomedicines for photodynamic therapy of cancer
07/19/2012US20120184494 Multiple myeloma prognosis and treatment
07/19/2012US20120184493 Dermal formulations of dp2 receptor antagonists
07/19/2012US20120184492 Therapeutic use of a growth factor, nsg33
07/19/2012US20120184491 Methods and Compound to Inhibit Ca2+ Permeable Cation Conductance
07/19/2012US20120184490 Enhancement of bmp retention
07/19/2012US20120184489 Prodrugs comprising an insulin linker conjugate
07/19/2012US20120184488 Insulin analogues of enhanced receptor-binding specificity
07/19/2012US20120184487 Insulin derivatives
07/19/2012US20120184486 Dioxa-bicyclo[3.2.1]octane-2,3,4-triol derivatives
07/19/2012US20120184485 Uses of cystatin
07/19/2012US20120184484 Lactoferrin and brain health and development in infants
07/19/2012US20120184483 Lactoferrin and neuronal health and development in the infant gut
07/19/2012US20120184482 Novel Ubiquitin-Isopeptide Probes
07/19/2012US20120184481 Variants of pigment epithelium derived factor and uses thereof
07/19/2012US20120184480 Use of constrained dipeptide and tripeptide mimic oligomers as vectorization agents
07/19/2012US20120184031 Antisense inhibition via rnase h-independent reduction in mrna
07/19/2012US20120183964 Mammalian cytokine; related reagents
07/19/2012US20120183630 Compositions and methods for stimulating wound healing
07/19/2012US20120183629 Low viscosity liquid polymeric delivery system
07/19/2012US20120183620 mesoporous drug delivery system using an electrically conductive polymer
07/19/2012US20120183616 Long acting insulin composition
07/19/2012US20120183601 Compositions And Methods For Regulation Of Tumor Necrosis Factor-Alpha
07/19/2012US20120183598 Hla-a2 tumor associated antigen peptides and compositions
07/19/2012US20120183596 Encapsulation of Plasmid DNA (Lipogenes) and Therapeutic Agents with Nuclear Localization Signal/Fusogenic Peptide Conjugates into Targeted Liposome Complexes
07/19/2012US20120183593 Hydrogels used to deliver medicaments to the eye for the treatment of posterior segment diseases
07/19/2012US20120183589 Lipid Nanoparticles For Gene Therapy
07/19/2012US20120183585 Gel based wound dressing and a method of synthesizing the same
07/19/2012US20120183582 Oral Delivery of Peptides
07/19/2012US20120183580 Analgesic Composition for Transbuccal Administration
07/19/2012US20120183568 Bioassay for the early detection of autoimmune diseases
07/19/2012US20120183564 Inhibition of endosomal toll-like receptor activation
07/19/2012US20120183562 Secreted fxyd proteins expressed in response to epithelial tissue damage, and uses therefor
07/19/2012US20120183554 Biomarker
07/19/2012US20120183553 Treatment and diagnosis of immune disorders
07/19/2012US20120183550 Therapeutic Using a Bispecific Antibody
07/19/2012US20120183548 IL-27 Antagonists for Treating Inflammatory Diseases
07/19/2012US20120183547 Compositions and methods comprising vegfr-2 and vegfr-3 antagonists for the treatment of metastatic disease
07/19/2012US20120183544 Diagnosis and treatment of neuroectodermal tumors
07/19/2012US20120183543 Diagnostic biomarkers for fibrotic disorders
07/19/2012US20120183541 Hair growth methods using fgfr4 extracellular domains
07/19/2012US20120183540 Methods of promoting fat loss comprising administering an alk7 inhibitor
07/19/2012US20120183538 Sparc antisense compositions and uses thereof
07/19/2012US20120183536 Methods of using corticotropin-releasing factor for the treatment of cancer
07/19/2012US20120183532 Compounds stimulating undesirable cellular adhesion and applications thereof
07/19/2012US20120183531 Methods for Inhibiting Yellow Color Formation in a Composition
07/19/2012US20120183525 Fibrinogenolytic enzyme tabfiblysin of horsefly, tabanus yao, encoding gene and use thereof
07/19/2012US20120183524 Molecular targets for treatment of inflammation
07/19/2012US20120183523 Methods and Compounds for Promoting Vessel Regression
07/19/2012US20120183522 Biaryl pde4 inhibitors for treating inflammatory, cardiovascular and cns disorders
07/19/2012US20120183521 Equine nutritional supplement
07/19/2012US20120183520 Minimally invasive methods for treating dysfunction of cardiac muscle
07/19/2012US20120183519 Treatment of erectile dysfunction using platelet-rich plasma
07/19/2012US20120183508 Gamma secretase inhibitor for treatment of herpesvirus infection
07/19/2012US20120183502 Combination therapy for lysosomal storage diseases
07/19/2012US20120183501 Novel method for treatment of skin wounds and preparations for implementation of same
07/19/2012US20120183500 Articles and methods including stable thermally-responsive polymers
07/19/2012US20120183499 Method of treating pulmonary disease with interferons
07/19/2012US20120183498 Compounds, compositions and methods for treating or preventing pneumovirus infection and associated diseases
07/19/2012US20120183497 Method of Determining Response to Treatment with Immunomodulatory Composition
07/19/2012US20120183496 Inhibitors of hepatitis c virus polymerase
07/19/2012US20120183495 Avian colony stimulating factor 1 receptor binding proteins
07/19/2012US20120183472 Immunotherapy of b-cell malignancies using anti-cd22 antibodies
1 ... 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 ... 3163